News

Published on 22 Jan 2025 on Zacks · via Yahoo Finance

Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out?


Article preview image

Zacks Rank We also need to consider the stock's Zacks Rank, as this supersedes any trend on the...

NYSE.RMD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
TEM Stock Rises on Launch of AI-Powered Health Concierge App

Tempus AI announces the launch of olivia, an AI-enabled personal health concierge app designed to...

Zacks · via Yahoo Finance 23 Jan 2025

Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out?

Zacks Rank We also need to consider the stock's Zacks Rank, as this supersedes any trend on the...

Zacks · via Yahoo Finance 22 Jan 2025

Emerging Market Expansion Supports ZBH Stock Amid Macro Issues

For the full year, the company currently expects an adverse impact of 75 basis points from foreig...

Zacks · via Yahoo Finance 21 Jan 2025

Reasons to Retain TNDM Stock in Your Portfolio for Now

Key Picks Some better-ranked stocks in the broader medical space are Veracyte VCYT, Omnicell OMCL...

Zacks · via Yahoo Finance 21 Jan 2025

Align Technology Shares Hurt by Macro Issues, Decline in ASPs

For Align Technology ALGN, we remain concerned about the current economic uncertainty, which...

Zacks · via Yahoo Finance 16 Jan 2025

HSIC Stock Might Rise Following the Acquisition of Acentus

Henry Schein, Inc. HSIC recently completed the acquisition of substantially all of the assets of...

Zacks · via Yahoo Finance 16 Jan 2025

The Zacks Analyst Blog Highlights Vertiv, Goldman Sachs, ResMed, Ralph Lauren...

It delivered an earnings surprise of 29.33%, on average, for the past four quarters. GS is slated...

Zacks · via Yahoo Finance 15 Jan 2025

5 Sectors and Stocks Set to Shine This Earnings Season

The fourth-quarter 2024 earnings season will kick off this week, with banking sector players due ...

Zacks 13 Jan 2025

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Revvity, Inc. RVTY announced the receipt of the FDA’s 510(k) clearance for EUROIMMUN’s automated...

Zacks · via Yahoo Finance 13 Jan 2025

Is There An Opportunity With ResMed Inc.'s (NYSE:RMD) 31% Undervaluation?

In this calculation we've used 6.5%, which is based on a levered beta of 0.946. Beta is a measure...

Simply Wall St. · via Yahoo Finance 11 Jan 2025